Double esters
    86.
    发明授权
    Double esters 有权
    双酯

    公开(公告)号:US07629383B2

    公开(公告)日:2009-12-08

    申请号:US10496328

    申请日:2002-11-22

    申请人: Jo Klaveness

    发明人: Jo Klaveness

    IPC分类号: A61K31/225 C07C69/52

    摘要: The invention provides acyloxymethyl esters of C6-14 alkane-dicarboxylic acids, or physiologically tolerable salts or esters thereof, for use in medicine as therapeutic or prophylactic agents.

    摘要翻译: 本发明提供了用作医药或预防药物的C 6-14烷烃二羧酸的酰氧基甲基酯或其生理上可耐受的盐或酯。

    Pyrazolidinol compounds
    88.
    发明申请
    Pyrazolidinol compounds 审中-公开
    吡唑啉醇化合物

    公开(公告)号:US20080287390A1

    公开(公告)日:2008-11-20

    申请号:US12007694

    申请日:2008-01-14

    摘要: The invention provides the use of an optionally hydroxyl-protected 4-hydroxy or hydroperoxy-3,5-dioxopyrazolidine or an equivalent wherein a pyrazolidine ring attached oxygen is replaced by a sulphur, or a physiologically acceptable salt thereof, for the manufacture of a medicament for use in drug therapy or prophylaxis. Additionally, the invention provides a method of combating HIV infection which comprises administering to an HIV-infected patient a T-lymphocyte growth suppressing agent, preferably a pyrazolidinol, in an amount sufficient to suppress T-lymphocyte growth in said patient for a period sufficient to reduce the T-lymphocyte concentration in lymph nodes in said patient.

    摘要翻译: 本发明提供任选羟基保护的4-羟基或氢过氧-3,5-二氧杂吡唑烷或其等价物,其中连接有吡唑烷环的氧被硫或其生理上可接受的盐替代,用于制备药物 用于药物治疗或预防。 另外,本发明提供了一种抗艾滋病毒感染的方法,其包括以足以抑制所述患者的T淋巴细胞生长的量向HIV感染的患者施用T淋巴细胞生长抑制剂,优选吡唑烷醇,时间足以 降低患者淋巴结中的T淋巴细胞浓度。

    Acid Addition Salts Of-5-Aminolevulinic Acid Or Its Derivatives
    89.
    发明申请
    Acid Addition Salts Of-5-Aminolevulinic Acid Or Its Derivatives 有权
    5-氨基乙酰丙酸或其衍生物的酸加成盐

    公开(公告)号:US20080064752A1

    公开(公告)日:2008-03-13

    申请号:US10594361

    申请日:2005-03-29

    CPC分类号: A61K41/0061 C07C229/22

    摘要: The present invention provides an acid addition salt of 5-aminolevulinic acid (5-ALA) or of a 5-ALA derivative (e.g. a 5-ALA ester) with an acid which has a pKa of about 5 or less, preferably about 3 or less, with the proviso that the acid is other than hydrochloric acid. Particularly preferred salts are those derived from acids selected from the group comprising sulphonic acid and its derivatives, hydrobromic acid, sulfuric acid, nitric acid and phosphoric acid. The salts in accordance with the invention are particularly suitable for use as photosensitizing agents in diagnosis and photochemotherapy of disorders or abnormalities of external or internal surfaces of the body.

    摘要翻译: 本发明提供5-氨基乙酰丙酸(5-ALA)或5-ALA衍生物(例如5-ALA酯)与酸的加成盐,所述酸的pKa为约5或更小,优选约3或 较少,条件是酸不是盐酸。 特别优选的盐是衍生自选自磺酸及其衍生物,氢溴酸,硫酸,硝酸和磷酸的酸的酸。 根据本发明的盐特别适用于诊断和光化学治疗身体的外表面或内表面的病症或异常的光敏剂。

    Optical Imaging Contrast Agents
    90.
    发明申请
    Optical Imaging Contrast Agents 审中-公开
    光学成像对比剂

    公开(公告)号:US20070258904A1

    公开(公告)日:2007-11-08

    申请号:US10582679

    申请日:2004-12-17

    IPC分类号: A61K49/00 C12N15/00

    摘要: The invention provides contrast agents for optical imaging of oesophageal cancer and Barrett's oesophagus in patients. The contrast agents may be used in diagnosis of oesophageal cancer and Barrett's oesophagus, for follow up of progress in disease development, for follow up of treatment of oesophageal cancer and Barrett's oesophagus and for surgical guidance. Further, the invention provides methods for optical imaging of oesophageal cancer and Barrett's oesophagus in patients.

    摘要翻译: 本发明提供了用于患者食管癌和Barrett食管的光学成像的造影剂。 造影剂可用于食管癌和巴雷特食管的诊断,用于跟踪疾病发展进展,跟进食管癌和巴雷特食管的治疗以及手术指导。 此外,本发明提供了食管癌和Barrett食管的光学成像方法。